Brokerages Set Afya Limited (NASDAQ:AFYA) Price Target at $17.60

Shares of Afya Limited (NASDAQ:AFYA) have been given an average recommendation of “Reduce” by the five research firms that are currently covering the company, Marketbeat.com reports. Two equities research analysts have rated the stock with a sell rating and three have given a hold rating to the company. The average twelve-month price objective among brokers that have issued a report on the stock in the last year is $17.40.

A number of brokerages recently issued reports on AFYA. UBS Group reaffirmed a “neutral” rating and issued a $19.50 price target (up from $17.50) on shares of Afya in a report on Thursday, June 12th. Citigroup raised Afya from a “sell” rating to a “neutral” rating and lowered their price target for the company from $16.00 to $14.00 in a report on Tuesday. Finally, Wall Street Zen downgraded Afya from a “buy” rating to a “hold” rating in a report on Saturday.

Institutional Investors Weigh In On Afya

Several large investors have recently modified their holdings of the company. Doma Perpetual Capital Management LLC boosted its holdings in shares of Afya by 4.4% in the first quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company’s stock valued at $10,619,000 after acquiring an additional 25,111 shares during the period. Renaissance Technologies LLC raised its stake in shares of Afya by 14.0% during the fourth quarter. Renaissance Technologies LLC now owns 412,000 shares of the company’s stock worth $6,543,000 after purchasing an additional 50,700 shares during the last quarter. Perpetual Ltd raised its stake in shares of Afya by 1.8% during the second quarter. Perpetual Ltd now owns 151,180 shares of the company’s stock worth $2,700,000 after purchasing an additional 2,730 shares during the last quarter. Lazard Asset Management LLC raised its stake in shares of Afya by 54.3% during the fourth quarter. Lazard Asset Management LLC now owns 97,313 shares of the company’s stock worth $1,545,000 after purchasing an additional 34,246 shares during the last quarter. Finally, D. E. Shaw & Co. Inc. raised its stake in shares of Afya by 32.9% during the fourth quarter. D. E. Shaw & Co. Inc. now owns 82,817 shares of the company’s stock worth $1,315,000 after purchasing an additional 20,498 shares during the last quarter. 88.02% of the stock is owned by institutional investors and hedge funds.

Afya Stock Performance

Shares of Afya stock opened at $14.18 on Friday. The business has a 50-day simple moving average of $17.10 and a 200-day simple moving average of $17.35. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.42 and a current ratio of 1.42. The company has a market cap of $1.33 billion, a PE ratio of 10.74, a P/E/G ratio of 0.49 and a beta of 0.58. Afya has a one year low of $13.47 and a one year high of $19.90.

About Afya

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.